Category: Cardiopulmonary & Thoracic

Cardiopulmonary & Thoracic

New DNA Markers May Predict Lung Cancer Recurrence

Specific circular DNA features found in blood and tissue could help clinicians identify patients at high risk for recurrence after surgery.

Cardiopulmonary & Thoracic

FDA Approves Zidesamtinib for Specific Type of Lung Cancer

Zidesamtinib (Jideytro) is approved for patients with ROS1-positive non-small cell lung cancer who have previously received targeted therapy.

Cardiopulmonary & Thoracic

‘Robotic’ Lung Transplant Successful at Houston Hospital

The minimally invasive surgical approach may allow high-risk or frail patients to become candidates for lung transplantation.

Pulmonary Hypertension

Ralinepag Reduced Pulmonary Arterial Hypertension Progression

Phase 3 trial results show ralinepag significantly reduced the risk of worsening symptoms and improved exercise capacity in pulmonary arterial hypertension patients.

Pulmonary Embolism

Ai Matches Radiologists in Detecting Pulmonary Embolism

A study of more than 32,000 CTPA scans found that artificial intelligence and physicians agreed on pulmonary embolism results nearly 98% of the time, though human review caught cases the software missed.

Thoracic Surgery

Geographic Disparities in Lung Transplant Access Persist

Recent updates to the national lung allocation system have not eliminated regional differences in donor availability.

Lung Cancer

Nanoparticles Increase Lung Cancer Drug Delivery 30-fold

Researchers at Adelaide University developed a lipid-polymer vehicle that improves drug bioavailability and reduces systemic toxicity in preclinical models of lung cancer.